QNTM Quantum BioPharma Ltd.
Company Analysis
Latest News
🔴 Quantum BioPharma is trading 5.91% down in pre-market with no fresh company-specific catalyst identified
Quantum BioPharma is trading 5.91% down in pre-market at $3.50, with no fresh company-specific catalyst identified. - No new overnight earnings, regulatory,...
🟢 Quantum BioPharma is trading 5.3% up today after Rodman & Renshaw initiated coverage with a BUY rating
Quantum BioPharma is trading 5.3% up now at $3.80 after Rodman & Renshaw initiated coverage on September 17, 2026, with a BUY rating and an US$8 price...
🟢 Quantum BioPharma is trading 5.8% up today after its ArcStone-Kingswood Growth Summit presentation
Quantum BioPharma is trading at $3.66 (+5.78%) after its September 16, 2026 presentation at the ArcStone-Kingswood Growth Summit. • The presentation...
🔴 Quantum BioPharma is trading 5.23% down in after-hours trading as broader risk-off sentiment pressures U.S. equities
Quantum BioPharma is trading 5.23% down at $3.28 as broader risk-off sentiment pressures U.S. equities. - Elevated Treasury yields, energy costs, and...
🟢 Quantum BioPharma is trading 10.62% up today after renewed attention to FDA clearance for its Phase 2 Lucid-MS trial
Quantum BioPharma is trading 10.62% up at $3.54 after renewed attention to FDA clearance for its Phase 2 Lucid-MS trial in multiple sclerosis. - A September...
🟢 Quantum BioPharma is trading 6.25% up today after FDA clearance for Phase 2 Lucid-MS trial
Quantum BioPharma is trading 6.25% up at $3.40 after renewed attention to its September 11 FDA-clearance announcement for a Phase 2 Lucid-MS trial in multiple...
🔴 Quantum BioPharma is trading 10.34% down today as broader risk-off sentiment weighs on equities
Quantum BioPharma is trading 10.34% down now at $3.21 as broader risk-off sentiment weighs on equities. - The S&P 500, Nasdaq Composite, and Dow Jones are...
🔴 Quantum BioPharma is trading 5% down today amid broader market weakness
Quantum BioPharma is trading 5% down at $3.40 after opening amid broader market weakness and ahead of inflation-sensitive trading. - No new company-specific...
🔴 Quantum BioPharma is trading 5% down in pre-market as Nasdaq futures fall ahead of inflation data
Quantum BioPharma is trading 5% down at $3.40, with broader market pressure potentially contributing. - The previous session saw an 8.81% gain to $3.58. - No...
Quantum BioPharma's FDA Green Light for Its MS Drug Sparks a Rally — But Can a $22 Million Company Really Crack a $38 Billion Market?
Shares of Quantum BioPharma (NASDAQ: QNTM) surged as much as 10.6% to $3.64 on September 9 — bucking a down market — after fresh coverage highlighted the FDA's...
🟢 Quantum BioPharma is trading 10.64% up today after FDA clearance for Lucid-MS Phase 2 testing
Quantum BioPharma is trading 10.64% up now at $3.64 after September 9, 2026 coverage spotlighted FDA clearance for Lucid-MS to enter Phase 2 testing in...
🟢 Quantum BioPharma is trading 5.78% up today after FDA-clearance coverage of Lucid-MS Phase 2 trials
Quantum BioPharma is trading 5.78% up now at $3.48 after September 9, 2026 coverage highlighted FDA clearance to begin Phase 2 trials of Lucid-MS, its...
🟢 Quantum BioPharma is trading 6.48% up in pre-market — no clear company-specific catalyst identified
Quantum BioPharma is trading at $3.45, up +6.48%, amid catalyst-unclear speculative or technical pre-market activity. - No new company-specific announcement...
🟢 Quantum BioPharma is trading 5.25% up today
Quantum BioPharma is trading 5.25% up at $3.10, with no reliable source attributing the advance to a new announcement or confirmed catalyst. - The move...
🔴 Quantum BioPharma is trading 5% down today after announcing planned CSE delisting
Quantum BioPharma is trading 5.26% down now at $2.92 after announcing plans to voluntarily delist its Class B shares from the Canadian Securities Exchange. •...
🟢 Quantum BioPharma is trading 5% up in after-hours trading on Rodman & Renshaw’s Buy rating
Quantum BioPharma is trading at $3.20 (+5.26%) in after-hours trading after Rodman & Renshaw initiated coverage with a Buy rating and an $8.00 price target,...
🟢 Quantum BioPharma is trading 5% up today after Rodman & Renshaw initiated coverage
Quantum BioPharma is trading 5.04% up now at $3.23 after Rodman & Renshaw initiated coverage on August 31, 2026, with a Buy rating and an $8.00 price target...
🔴 Quantum BioPharma is trading 5.69% down in pre-market with no fresh company-specific catalyst identified
Quantum BioPharma is trading 5.69% down at $2.90 after no fresh company-specific catalyst was identified for August 31, 2026. - Recent coverage centers on the...
🔴 Quantum BioPharma is trading 5% down today with no clear company-specific catalyst
Quantum BioPharma is trading 5.03% down at $3.12, with no clear company-specific catalyst identified for August 26, 2026. - Recent updates—including lower...
🔴 Quantum BioPharma is trading 5% down in pre-market with no clear company-specific catalyst
Quantum BioPharma is trading 5.19% down now at $3.11, with no clear company-specific catalyst identified in available August 26, 2026 overnight coverage. -...